Johnson & Johnson Innovative Medicine 2026 Pipeline: How Talvey, Darzalex, and Tremfya Are Offsetting the Stelara Cliff on the Path to $282
Johnson & Johnson’s Innovative Medicine pipeline turns the Stelara cliff into a re-rating setup at 18.4x forward P/E. Base $255, bull $282.